| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2008;39:1205.)
© 2008 American Heart Association, Inc.
Original Contributions |
From the Departments of Neurology (W.S.S.) and Radiology (R.T.H.), University of California, San Francisco, San Francisco, Calif; the Department of Neurology (G.S.), University of Southern California, Los Angeles, Calif; the Departments of Neurology (J.S., D.S.L.), Radiology (G.D.), and Emergency Medicine (S.S.), University of California, Los Angeles, Los Angeles, Calif; Riverside Methodist Hospital (R.B.), Columbus, Ohio; Oregon Health Sciences (H.L.L.), Portland, Ore; St Lukes Hospital (M.M.R.), Kansas City, Kan; and the Department of Radiology (Y.P.G.), New York Presbyterian Hospital–Cornell, New York, NY.
Correspondence to Wade S. Smith, MD, PhD, Department of Neurology, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143-0114. E-mail smithw{at}neurology.ucsf.edu
Background and Purpose— Endovascular mechanical thrombectomy may be used during acute ischemic stroke due to large vessel intracranial occlusion. First-generation MERCI devices achieved recanalization rates of 48% and, when coupled with intraarterial thrombolytic drugs, recanalization rates of 60% have been reported. Enhancements in embolectomy device design may improve recanalization rates.
Methods— Multi MERCI was an international, multicenter, prospective, single-arm trial of thrombectomy in patients with large vessel stroke treated within 8 hours of symptom onset. Patients with persistent large vessel occlusion after IV tissue plasminogen activator treatment were included. Once the newer generation (L5 Retriever) device became available, investigators were instructed to use the L5 Retriever to open vessels and could subsequently use older generation devices and/or intraarterial tissue plasminogen activator. Primary outcome was recanalization of the target vessel.
Results— One hundred sixty-four patients received thrombectomy and 131 were initially treated with the L5 Retriever. Mean age±SD was 68±16 years, and baseline median (interquartile range) National Institutes of Health Stroke Scale score was 19 (15 to 23). Treatment with the L5 Retriever resulted in successful recanalization in 75 of 131 (57.3%) treatable vessels and in 91 of 131 (69.5%) after adjunctive therapy (intraarterial tissue plasminogen activator, mechanical). Overall, favorable clinical outcomes (modified Rankin Scale 0 to 2) occurred in 36% and mortality was 34%; both outcomes were significantly related to vascular recanalization. Symptomatic intracerebral hemorrhage occurred in 16 patients (9.8%); 4 (2.4%) of these were parenchymal hematoma type II. Clinically significant procedural complications occurred in 9 (5.5%) patients.
Conclusions— Higher rates of recanalization were associated with a newer generation thrombectomy device compared with first-generation devices, but these differences did not achieve statistical significance. Mortality trended lower and the proportion of good clinical outcomes trended higher, consistent with better recanalization.
Key Words: acute stroke fibrinolytic thrombectomy
This article has been cited by other articles:
![]() |
M. Moonis Intraarterial Thrombolysis Within the First Three Hours After Acute Ischemic Stroke in Selected Patients Stroke, July 1, 2009; 40(7): 2611 - 2612. [Full Text] [PDF] |
||||
![]() |
J. L. Saver, G. W. Albers, B. Dunn, K. C. Johnston, M. Fisher, and for the STAIR VI Consortium Stroke Therapy Academic Industry Roundtable (STAIR) Recommendations for Extended Window Acute Stroke Therapy Trials Stroke, July 1, 2009; 40(7): 2594 - 2600. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Yoo, L. A. Verduzco, P. W. Schaefer, J. A. Hirsch, J. D. Rabinov, and R. G. Gonzalez MRI-Based Selection for Intra-Arterial Stroke Therapy: Value of Pretreatment Diffusion-Weighted Imaging Lesion Volume in Selecting Patients With Acute Stroke Who Will Benefit From Early Recanalization Stroke, June 1, 2009; 40(6): 2046 - 2054. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Wasiewski and K. C. Johnston Clinical Trials, Devices, Unproven Treatments, and Clinical Equipoise Stroke, June 1, 2009; 40(6): e441 - e442. [Full Text] [PDF] |
||||
![]() |
R.G. Nogueira, A.J. Yoo, F.S. Buonanno, and J.A. Hirsch Endovascular Approaches to Acute Stroke, Part 2: A Comprehensive Review of Studies and Trials AJNR Am. J. Neuroradiol., May 1, 2009; 30(5): 859 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Janjua, A. El-Gengaihy, J. Pile-Spellman, and A.I. Qureshi Late Endovascular Revascularization in Acute Ischemic Stroke Based on Clinical-Diffusion Mismatch AJNR Am. J. Neuroradiol., May 1, 2009; 30(5): 1024 - 1027. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Wakhloo, M. J. Deleo III, and M. M. Brown Advances in Interventional Neuroradiology Stroke, May 1, 2009; 40(5): e305 - e312. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Meyers, H. C. Schumacher, R. T. Higashida, S. L. Barnwell, M. A. Creager, R. Gupta, C. G. McDougall, D. K. Pandey, D. Sacks, and L. R. Wechsler Indications for the Performance of Intracranial Endovascular Neurointerventional Procedures: A Scientific Statement From the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research Circulation, April 28, 2009; 119(16): 2235 - 2249. [Full Text] [PDF] |
||||
![]() |
L.E. Cipriano, M.L. Steinberg, G.S. Gazelle, and R.G. Gonzalez Comparing and Predicting the Costs and Outcomes of Patients with Major and Minor Stroke Using the Boston Acute Stroke Imaging Scale Neuroimaging Classification System AJNR Am. J. Neuroradiol., April 1, 2009; 30(4): 703 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.G. Nogueira, L.H. Schwamm, and J.A. Hirsch Endovascular Approaches to Acute Stroke, Part 1: Drugs, Devices, and Data AJNR Am. J. Neuroradiol., April 1, 2009; 30(4): 649 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.J. Cloft, A. Rabinstein, G. Lanzino, and D.F. Kallmes Intra-Arterial Stroke Therapy: An Assessment of Demand and Available Work Force AJNR Am. J. Neuroradiol., March 1, 2009; 30(3): 453 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Brekenfeld, G. Schroth, H. P. Mattle, D.-D. Do, L. Remonda, P. Mordasini, M. Arnold, K. Nedeltchev, N. Meier, and J. Gralla Stent Placement in Acute Cerebral Artery Occlusion: Use of a Self-Expandable Intracranial Stent for Acute Stroke Treatment Stroke, March 1, 2009; 40(3): 847 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Soares, J. D. Chien, and M. Wintermark MR and CT Monitoring of Recanalization, Reperfusion, and Penumbra Salvage: Everything That Recanalizes Does Not Necessarily Reperfuse! Stroke, March 1, 2009; 40(3_suppl_1): S24 - S27. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Broderick Endovascular Therapy for Acute Ischemic Stroke Stroke, March 1, 2009; 40(3_suppl_1): S103 - S106. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Nogueira, W. S. Smith, and on Behalf of the MERCI and Multi MERCI Writing Com Safety and Efficacy of Endovascular Thrombectomy in Patients With Abnormal Hemostasis: Pooled Analysis of the MERCI and Multi MERCI Trials Stroke, February 1, 2009; 40(2): 516 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.T.L. Chiam, R.M. Samuelson, J. Mocco, R.A. Hanel, A.H. Siddiqui, L.N. Hopkins, and E.I. Levy Navigability Trumps All: Stenting of Acute Middle Cerebral Artery Occlusions with a New Self-Expandable Stent AJNR Am. J. Neuroradiol., November 1, 2008; 29(10): 1956 - 1958. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |